Galantamine and wedelolactone combined treatment suppresses LPS-induced NLRP3 inflammasome activation in microglial cells.

Saved in:
Bibliographic Details
Title: Galantamine and wedelolactone combined treatment suppresses LPS-induced NLRP3 inflammasome activation in microglial cells.
Authors: Saker D; Department of Histology and Embryology, Faculty of Medicine, Çukurova University, Adana, Turkey., Sencar L; Department of Histology and Embryology, Faculty of Medicine, Çukurova University, Adana, Turkey., Coskun G; Department of Histology and Embryology, Faculty of Medicine, Çukurova University, Adana, Turkey., Sapmaz Ercakalli T; Department of Histology and Embryology, Faculty of Medicine, Çukurova University, Adana, Turkey., Yilmaz DM; Department of Neurosurgery, Faculty of Medicine, Çukurova University, Adana, Turkey., Polat S; Department of Histology and Embryology, Faculty of Medicine, Çukurova University, Adana, Turkey.
Source: Immunopharmacology and immunotoxicology [Immunopharmacol Immunotoxicol] 2024 Dec; Vol. 46 (6), pp. 805-814. Date of Electronic Publication: 2024 Sep 18.
Publication Type: Journal Article
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8800150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2513 (Electronic) Linking ISSN: 08923973 NLM ISO Abbreviation: Immunopharmacol Immunotoxicol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1532-2513
DOI:10.1080/08923973.2024.2405579